About basiliximab
Interleukin-2 receptor antagonist immunosuppressant
Used for
- Prevents rejection after kidney transplantation, alongside other immunosuppressive medicines.
Usual adult dose
20 mg intravenously before transplant surgery and again four days later.
Usual dose in children
For children weighing 35 kg or more: 20 mg intravenously before surgery and on day four. Below 35 kg: 10 mg at each dose.
Common side effects
- Infections
- High blood pressure
- Constipation, nausea, or vomiting
- Low blood-cell counts
Important warnings
- Given by healthcare professionals in a transplant setting.
- Serious allergic reactions can occur during or after administration.
- May increase infection risk when combined with other immunosuppressants.
- Use only for kidney transplantation prevention; it is not treatment for rejection.
Pregnancy
There is limited information about use in pregnancy. Use only when the expected benefit justifies potential risk.
Breastfeeding
It is not known whether basiliximab passes into human milk. Discuss breastfeeding with the transplant team.
Interactions
- Other immunosuppressants can increase infection risk.
- Live vaccines may be less effective or unsafe during immunosuppressive treatment.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.